Hemolytic anemia classification: Difference between revisions

Jump to navigation Jump to search
Line 47: Line 47:
**[[Warm antibody autoimmune hemolytic anemia]]
**[[Warm antibody autoimmune hemolytic anemia]]
***[[Idiopathic]]
***[[Idiopathic]]
***[[Systemic lupus erythematosus]] (SLE)
***[[Systemic lupus erythematosus]] (SLE)<ref name="pmid25949934">{{cite journal| author=Fujii J, Kurahashi T, Konno T, Homma T, Iuchi Y| title=Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus. | journal=World J Nephrol | year= 2015 | volume= 4 | issue= 2 | pages= 213-22 | pmid=25949934 | doi=10.5527/wjn.v4.i2.213 | pmc=4419130 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25949934  }} </ref>
***[[Evans' syndrome]] (antiplatelet antibodies and haemolytic antibodies)
***[[Evans' syndrome]] (antiplatelet antibodies and haemolytic antibodies)
**[[Cold agglutinin disease|Cold antibody autoimmune hemolytic anemia]]
**[[Cold agglutinin disease|Cold antibody autoimmune hemolytic anemia]]

Revision as of 15:55, 24 October 2017

Hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI Scan

Echocardiography or Ultrasound

Imaging Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic anemia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic anemia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic anemia classification

CDC on Hemolytic anemia classification

Hemolytic anemia classification in the news

Blogs on Hemolytic anemia classification

Directions to Hospitals Treating Hemolytic anemia

Risk calculators and risk factors for Hemolytic anemia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Shyam Patel [2]

Overview

Hemolytic anemia can be divided into intravascular and extravascular based on whether the destruction of RBC occurs in the vessels or outside the vessels, usually in spleen and liver. Extravascular hemolytic anemia is more common than intravascular hemolytic anemia. There are many types of hemolytic anemias and the general classification of hemolytic anemia is either acquired or inherited (genetic). Genetic conditions include red blood cell membrane or enzyme defects that predispose the red blood cells to hemolysis.

Classification

Location of Hemolysis

  • Intravascular: This refers to red blood cell destruction within the blood vessels.
  • Extravascular: This refers to red blood cell destruction outside the blood vessels, such as in the liver or spleen.

Types of Hemolytic Anemias

Hemolytic anemias can be either genetic or acquired.

Genetic

Acquired

Acquired hemolytic anemia can be further divided into immune and non-immune mediated.

Immune-mediated hemolytic anemia (direct Coombs test is positive)

Non-immune mediated hemolytic anemia (direct Coombs test is negative)[2]

References

  1. Berentsen S, Sundic T (2015). "Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy". Biomed Res Int. 2015: 363278. doi:10.1155/2015/363278. PMC 4326213. PMID 25705656.
  2. 2.0 2.1 2.2 Packman CH (2015). "The Clinical Pictures of Autoimmune Hemolytic Anemia". Transfus Med Hemother. 42 (5): 317–24. doi:10.1159/000440656. PMC 4678314. PMID 26696800.
  3. Fujii J, Kurahashi T, Konno T, Homma T, Iuchi Y (2015). "Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus". World J Nephrol. 4 (2): 213–22. doi:10.5527/wjn.v4.i2.213. PMC 4419130. PMID 25949934.

Template:WS Template:WH